Shigatoxin Antibodies

Santa Cruz Biotechnology offers a broad range of Shigatoxin monoclonal antibodies for various research applications. Shigatoxin monoclonal antibodies are essential tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Shigatoxin, produced by certain strains of Shigella bacteria, plays a significant role in the pathogenesis of shigellosis, a severe intestinal infection. Shigatoxin disrupts protein synthesis in host cells, leading to cell death and contributing to the disease's symptoms. Understanding the mechanisms of Shigatoxin action is essential for developing therapeutic strategies and preventive measures against Shigella infections. Research into Shigatoxin mechanisms has revealed multiple pathways through which the toxin affects cellular functions. Investigating Shigatoxin interactions with host cells continues to uncover new aspects of bacterial pathogenesis. The molecular characterization of Shigatoxin has led to significant advances in understanding bacterial toxin mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of bacterial pathogenesis and developing new therapeutic approaches.